Health.
Evidence-led reading on health from the HL Benefits desk. Long reads, careful guides, and the boring-but-true positions the research keeps settling on.
Peptides That Restore Sleep for Women Over 45 (When Melatonin Stops Working)
When melatonin stops working after 45, these peptides target the real causes of perimenopausal insomnia: hormonal shifts, cortisol, and broken sleep architecture.
Photograph · HL BenefitsThe latest, in long form.
Browse all 186 →
The 5 Peptides Quietly Replacing HRT for Perimenopausal Women
Five peptides are gaining traction as targeted alternatives to HRT for perimenopausal symptoms. Only one has FDA approval.
Are Peptides Legal in 2026? The Post-FDA-Reversal Buyer's Guide
HealthPeptides for Hormonal Imbalance After Pregnancy: What New Moms Are Trying
HealthCan You Pay for Peptides with an HSA or FSA? The 2026 Tax Loophole Guide
Peptides for Hot Flashes: What Kisspeptin Research Just Revealed
Kisspeptin research revealed why hot flashes happen. But the treatment targets neurokinin B, not kisspeptin itself. Here's what the science actually shows.
How Much Does Peptide Therapy Really Cost in 2026? A No-BS Pricing Breakdown
Peptide therapy costs $150 to $1,200 per month in 2026. We break down actual prices by category, channel, and hidden fees.
Peptide Side Effects: The 12 Symptoms You Should Never Ignore
Twelve peptide side effects organized by severity: which to monitor, which need a same-day doctor call, and which mean go to the ER.
We started this section because the conversation about health had become unbearable — too loud, too certain, too often selling something. The boring middle — what the evidence actually supports, repeated across decades, written without a brand to defend — is not a position you can monetize, but it is the position the research keeps quietly settling on.
Companion sections.
All sections →Food & Nutrition
A companion section to health, with its own evidence-led reading list.
Weight Loss
A companion section to health, with its own evidence-led reading list.
Fitness
A companion section to health, with its own evidence-led reading list.
Definitive guides.
All guides →
Online Peptide Clinics: Which Ones Are Legit (and Which Ones to Run From)
The FDA has sent thousands of warning letters to peptide sellers. Here's how to tell a legitimate clinic from one selling mystery powder.
Kisspeptin: The Peptide That Could Replace Testosterone Therapy for Low Libido
An evidence-led look at kisspeptin: the upstream HPG-axis stimulator behind a 56% increase in penile rigidity in Imperial College London's HSDD trials, why it could (in theory) preserve fertility…
A claim about health is not a study. A study is not a meta-analysis. A meta-analysis is not a guideline. The article doesn't fit on a label.
On our desk this week.
More from the desk →
Insurance and Peptide Therapy: What Your Plan May Actually Cover in 2026
Insurance covers some peptides and excludes others. Here's the complete breakdown by plan type, plus how to appeal and use tax-advantaged accounts.
How Much Collagen Per Day Actually Does Anything? The Dose-Response Truth
The right collagen dose depends on your goal. Clinical trials show 2.5g works for skin, 5g for bones, 10g for joints, and 15g for muscle.
Quick reads.
All 186 →The 7 Red Flags of a Sketchy Peptide Vendor (Spot Them Before You Inject)
Seven signs a peptide vendor isn't worth your trust, backed by FDA enforcement data and…
The Peptide Stack That Fixed Chronic Tendinitis When Cortisone Couldn't
Cortisone keeps failing chronic tendinopathy. Here is the BPC-157, TB-500, GHK-Cu, and…
Is BPC-157 Safe? A Full Risk Breakdown for First-Time Users
BPC-157 safety is not settled. Learn what human studies, cancer concerns, and…
BPC-157 Dosage Guide: How Much, How Often, and When to Stop
BPC-157 has no approved human dose. Learn what common ranges, cycle lengths, and stop…
BPC-157 Oral vs. Injection: Which Form Actually Works for Joint Repair?
Oral BPC-157 is convenient and injectable BPC-157 is more targeted, but neither route is…
How Long Should You Stay on Weight Loss Peptides? The Answer Is Not "Forever"
STEP 1, STEP 4 and SURMOUNT-4 show what really happens when patients stop GLP-1…
BPC-157: Why the Internet Is Calling It the 'Wolverine Peptide'
BPC-157 picked up a Marvel-superhero nickname, a podcast spotlight, and an FDA panel…
BPC-157 for Gut Healing: The Research That Has Functional Medicine Doctors Excited
The FDA is reconsidering BPC-157 for ulcerative colitis. Here's the gut-specific…
From the archive.
All 186 →
Sauna Blanket: Infrared Heat Therapy at Home Without a Full Sauna
Precision Diagnostics: Biomarker Testing, Blood Panels, and At-Home Health Screening
PFAS (Forever Chemicals) in Drinking Water: Health Risks and How to Filter Them Out
Pet Supplements: CBD, Probiotics, and Joint Support for Dogs and Cats
PFAS in Cookware, Food Packaging, and Personal Care: How to Reduce Your Exposure
PFAS forever chemicals lurk in nonstick pans, food wrappers, and cosmetics. Here's what the research says and how to reduce your exposure.
Perimenopause Wearables and Hormone Tracking Tech for Women
New wearables and hormone monitors are giving women real data about perimenopause. Here is what works, what the research supports, and how to choose.
Ozempic and Muscle Preservation: How to Maintain Lean Mass on GLP-1 Drugs
GLP-1 drugs can cause 25-40% of weight lost to come from lean tissue. Resistance training and protein optimization can cut that to under 10%.
Low-Dose Naltrexone (LDN): Off-Label Uses for Autoimmune Disease, Pain, and Weight Loss
A research-grounded look at what LDN can and can't do for autoimmune conditions, chronic pain, and weight loss.
Gummy Supplements: Are They as Effective as Capsules? The Evidence Breakdown
Gummy vitamins outsell capsules, but clinical evidence shows they fall short for iron, creatine, and calcium while matching or beating tablets for vitamin D.
GLP-1 Drugs and Addiction: The Unexpected Effect on Alcohol, Smoking, and Cravings
Patients on GLP-1 drugs report losing interest in alcohol and cigarettes. A study of 606,000 veterans found 50% fewer substance-related deaths among GLP-1 users.